A SINGLE DOSE OF 8-OH-DPAT REDUCES RAPHE BINDING OF [H-3] 8-OH-DPAT AND INCREASES THE EFFECT OF RAPHE STIMULATION ON 5-HT METABOLISM

被引:64
作者
BEER, M
KENNETT, GA
CURZON, G
机构
[1] MERCK SHARP & DOHME LTD,NEUROSCI RES CTR,HARLOW CM20 2QR,ESSEX,ENGLAND
[2] INST NEUROL,DEPT NEUROCHEM,LONDON WC1N 3BG,ENGLAND
关键词
5-HT[!sub]1A[!/sub] receptor agonists; 5-Hydroxytryptamine; (5-HT; serotonin); 8-OH-DPAT(8-hydroxy-(di-n-propylamino)tetralin; Antidepressant; Electrical stimulation;
D O I
10.1016/0014-2999(90)90473-J
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
8-Hydroxy-(di-n-propylamino)tetralin (8-OH-DPAT) has antidepressant-like effects in rats and selectively reduces presynaptic 5-HT1A function a day after administration. In the present study, the effect of 8-OH-DPAT (1 mg/kg s.c.) pretreatment on presynaptic (raphe nuclei) and postsynaptic (frontal cortex and hippocampus) [3H]8-OH-DPAT binding was studied. Bmax values were markedly reduced in the raphe, but not in the hippocampus and frontal cortex. Kd values were unchanged. Electrical stimulation of the dorsal raphe (300 μA, 1 ms, 20 Hz, 30 min) significantly increased 5-hydroxyindoleacetic acid in the frontal cortex, but not in the amygdala or the nucleus accumbens and caused smaller increases in the rest of the brain. The increase in the frontal cortex was significantly potentiated one day after giving 8-OH-DPAT. These results confirm the ability of 8-OH-DPAT to desensitise presynaptic 5-HT1A receptors and suggest that this may lead to a loss of feedback control so that, on neuronal stimulation, the increase of 5-HT function is enhanced. This effect may underlie the antidepressant-like action of 8-OH-DPAT pretreatment, i.e. its ability to oppose restraint-induced defects in locomotion on placement in an open field one day later. A requirement of presynaptic 5-HT for this behavioural effect is consistent with its prevention by the 5-HT synthesis inhibitor parachlorophenylalanine. © 1990.
引用
收藏
页码:179 / 187
页数:9
相关论文
共 45 条
[1]   SEROTONIN - RELEASE IN FOREBRAIN BY STIMULATION OF MIDBRAIN RAPHE [J].
AGHAJANIAN, GK ;
ROSECRANS, JA ;
SHEARD, MH .
SCIENCE, 1967, 156 (3773) :402-+
[2]  
AMSTERDAM JD, 1987, CURR THER RES CLIN E, V41, P185
[3]   DEFICITS OF ESCAPE PERFORMANCE FOLLOWING CATECHOLAMINE DEPLETION - IMPLICATIONS FOR BEHAVIORAL DEFICITS INDUCED BY UNCONTROLLABLE STRESS [J].
ANISMAN, H ;
IRWIN, J ;
SKLAR, LS .
PSYCHOPHARMACOLOGY, 1979, 64 (02) :163-170
[4]   SEROTONINERGIC BUT NOT NORADRENERGIC NEURONS IN RAT CENTRAL-NERVOUS-SYSTEM ADAPT TO LONG-TERM TREATMENT WITH MONOAMINE-OXIDASE INHIBITORS [J].
BLIER, P ;
DEMONTIGNY, C .
NEUROSCIENCE, 1985, 16 (04) :949-955
[5]   MODIFICATION OF 5-HT NEURON PROPERTIES BY SUSTAINED ADMINISTRATION OF THE 5-HT1A AGONIST GEPIRONE - ELECTROPHYSIOLOGICAL STUDIES IN THE RAT-BRAIN [J].
BLIER, P ;
DEMONTIGNY, C .
SYNAPSE, 1987, 1 (05) :470-480
[6]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[7]   EFFECT OF 5-HT1A AGONISTS ON STRESS-INDUCED DEFICIT IN OPEN-FIELD LOCOMOTOR-ACTIVITY OF RATS - EVIDENCE THAT THIS MODEL IDENTIFIES ANXIOLYTIC-LIKE ACTIVITY [J].
CARLI, M ;
PRONTERA, C ;
SAMANIN, R .
NEUROPHARMACOLOGY, 1989, 28 (05) :471-476
[8]   POTENTIAL ANTIDEPRESSANT PROPERTIES OF 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN, A SELECTIVE SEROTONIN-1A RECEPTOR AGONIST [J].
CERVO, L ;
SAMANIN, R .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 144 (02) :223-229
[9]  
COTT JM, 1988, PSYCHOPHARMACOL BULL, V24, P164
[10]  
DEMONTIGNY C, 1984, FRONTIERS BIOCH PHAR, P223